autologous stored platelets

Phase 2Completed

0 watching 0 views this week⚡ Active

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Bleeding

Conditions

Bleeding

Trial Timeline

Nov 1, 2010 → Mar 1, 2011

NCT ID

NCT01248351

About autologous stored platelets

autologous stored platelets is a phase 2 stage product being developed by Novo Nordisk for Bleeding. The current trial status is completed. This product is registered under clinical trial identifier NCT01248351. Target conditions include Bleeding.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT01248351	Phase 2	Completed	Nov 1, 2010	Mar 1, 2011	Bleeding

Competing Products

20 competing products in Bleeding

See all competitors

Product	Company	Stage	Hype Score
60mg edoxaban + 180mg edoxaban + 50 IU/kg Beriplex P/N + 25 IU/kg Beriplex P/N + 10 IU/kg Beriplex P/N	Daiichi Sankyo	Phase 1	33
Elagolix + 0.5 mg estradiol / 0.1 mg norethindrone acetate + 1 mg estradiol / 0.5 mg norethindrone acetate + E2/NETA placebo	AbbVie	Phase 2	52
Elagolix + Placebo + Estradiol/Norethindrone acetate (E2/NETA) + Estradiol + Progesterone	AbbVie	Phase 2	52
Elagolix + Estradiol /norethindrone acetate (E2/NETA)	AbbVie	Phase 3	77
Risk of selected safety events	AstraZeneca	Pre-clinical	23
Anticoagulant	AstraZeneca	Pre-clinical	23
Esomeprazole Na + Cimetidine + Esomeprazole Mg	AstraZeneca	Phase 3	77
Tamoxifen + Placebo + Tamoxifen (open label)	Merck	Approved	85
Placebo + Curcumin	Merck	Approved	85
Desogestrel 75 micrograms POP (Cerazette), Etonogestrel 68 mg implant (Nexplanon) + Etonogestrel 68 mg subdermal implant	Merck	Approved	85
Octreotide LAR Depot	Novartis	Phase 1	33
activated recombinant human factor VII	Novo Nordisk	Pre-clinical	22
turoctocog alfa + turoctocog alfa	Novo Nordisk	Phase 3	76
catridecacog + recombinant factor XIII	Novo Nordisk	Phase 1	32
eptacog alfa (activated) + placebo	Novo Nordisk	Phase 3	76
activated recombinant human factor VII + activated recombinant human factor VII	Novo Nordisk	Phase 1	32
activated recombinant human factor VII	Novo Nordisk	Phase 2	51
turoctocog alfa pegol	Novo Nordisk	Phase 3	76
recombinant factor XIII	Novo Nordisk	Pre-clinical	22
activated recombinant human factor VII, long acting + activated recombinant human factor VII, long acting	Novo Nordisk	Phase 1	32

Other Products from Novo Nordisk

Liraglutide 3.0mg + Placebo Oral Tablet + Phentermine 15 MGApproved

Liraglutide + SalineApproved

Hydrocortisone + PlaceboApproved

biphasic insulin aspart + insulin aspartApproved

Semaglutide, 1.34 mg/mL + Empagliflozin 25 MGApproved